Avadel Pharmaceuticals PLC (AVDL)
18.13
+0.31
(+1.74%)
USD |
NASDAQ |
Apr 26, 09:59
Avadel Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2020 | 47.56M |
| March 31, 2020 | 55.02M |
| December 31, 2019 | 59.22M |
| September 30, 2019 | 69.14M |
| June 30, 2019 | 74.74M |
| March 31, 2019 | 86.41M |
| December 31, 2018 | 103.27M |
| September 30, 2018 | 117.10M |
| June 30, 2018 | 136.95M |
| March 31, 2018 | 154.03M |
| December 31, 2017 | 173.24M |
| September 30, 2017 | 181.58M |
| June 30, 2017 | 173.99M |
| March 31, 2017 | 166.54M |
| December 31, 2016 | 150.25M |
| September 30, 2016 | 151.73M |
| June 30, 2016 | 166.96M |
| March 31, 2016 | 176.70M |
| December 31, 2015 | 173.21M |
| September 30, 2015 | 119.33M |
| June 30, 2015 | 79.05M |
| March 31, 2015 | 34.76M |
| December 31, 2014 | 6.614M |
| September 30, 2014 | 3.839M |
| June 30, 2014 | 2.394M |
| Date | Value |
|---|---|
| March 31, 2014 | 3.617M |
| December 31, 2013 | 4.179M |
| September 30, 2013 | 5.007M |
| June 30, 2013 | 4.822M |
| March 31, 2013 | 5.314M |
| December 31, 2012 | 7.534M |
| September 30, 2012 | 27.44M |
| June 30, 2012 | 32.48M |
| March 31, 2012 | 33.20M |
| December 31, 2011 | 32.60M |
| September 30, 2011 | 37.40M |
| June 30, 2011 | 35.01M |
| March 31, 2011 | 35.77M |
| December 31, 2010 | 37.09M |
| September 30, 2010 | 34.23M |
| June 30, 2010 | 36.09M |
| March 31, 2010 | 38.15M |
| December 31, 2009 | 42.12M |
| September 30, 2009 | 40.99M |
| June 30, 2009 | 40.23M |
| March 31, 2009 | 39.81M |
| December 31, 2008 | 38.62M |
| September 30, 2008 | 39.71M |
| June 30, 2008 | 39.60M |
| March 31, 2008 | 37.89M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
47.56M
Minimum
Jun 2020
74.74M
Maximum
Jun 2019
61.13M
Average
59.22M
Median
Dec 2019
Revenue (TTM) Benchmarks
| Trinity Biotech PLC | 71.39M |
| Medtronic PLC | 32.32B |
| Biophytis SA | -- |
| Jazz Pharmaceuticals PLC | 3.834B |
| DBV Technologies SA | -- |